Eliminación de la transmisión vertical del VIH mediante terapia antirretroviral: ¿Es posible prevenir todos los casos?
Contenido principal del artículo
Keywords
Citas
1. World Health Organization. Global HIV Programme: Mother-to-child transmission of HIV [Internet]. [consultado 2023 Dic 18]. Disponible en: https://www.who.int/teams/global-hiv-hepatitis-and-stis-programmes/hiv/prevention/mother-to-child-transmission-of-hiv
2. World Health Organization. Global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022-2030 [Internet]. [consultado 2023 Dic 18]. Disponible en: https://www.who.int/publications/i/item/9789240053779
3. Sibiude J, Le Chenadec J, Mandelbrot L, Hoctin A, Dollfus C, Faye A, et al. Update of Perinatal Human Immunodeficiency Virus Type 1 Transmission in France: Zero Transmission for 5482 Mothers on Continuous Antiretroviral Therapy From Conception and With Undetectable Viral Load at Delivery. Clin Infect Dis. 2023;76(3). Doi: 10.1093/cid/ciac703 PMID: 36037040.
4. Uthman OA, Nachega JB, Anderson J, Kanters S, Mills EJ, Renaud F, et al. Timing of initiation of antiretroviral therapy and adverse pregnancy outcomes: a systematic review and meta-analysis. Lancet HIV. 2017;4(1). Doi: 10.1016/S2352-3018(16)30195-3
5. Horner MJ, Hazra R, Barnholtz-Sloan JS, Shiels MS, Engels EA. Cancer risk among HIV-exposed uninfected children in the United States. AIDS. 2023; 37(3):549-551. Doi: 10.1097/QAD.0000000000003458.
2. World Health Organization. Global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022-2030 [Internet]. [consultado 2023 Dic 18]. Disponible en: https://www.who.int/publications/i/item/9789240053779
3. Sibiude J, Le Chenadec J, Mandelbrot L, Hoctin A, Dollfus C, Faye A, et al. Update of Perinatal Human Immunodeficiency Virus Type 1 Transmission in France: Zero Transmission for 5482 Mothers on Continuous Antiretroviral Therapy From Conception and With Undetectable Viral Load at Delivery. Clin Infect Dis. 2023;76(3). Doi: 10.1093/cid/ciac703 PMID: 36037040.
4. Uthman OA, Nachega JB, Anderson J, Kanters S, Mills EJ, Renaud F, et al. Timing of initiation of antiretroviral therapy and adverse pregnancy outcomes: a systematic review and meta-analysis. Lancet HIV. 2017;4(1). Doi: 10.1016/S2352-3018(16)30195-3
5. Horner MJ, Hazra R, Barnholtz-Sloan JS, Shiels MS, Engels EA. Cancer risk among HIV-exposed uninfected children in the United States. AIDS. 2023; 37(3):549-551. Doi: 10.1097/QAD.0000000000003458.
Barra lateral del artículo
Publicado
jun 28, 2024
Detalles del artículo
Cómo citar
Prins-Diaz, I. E., Mora-Sánchez, D. P., Vergara-Jacome, Y. A., & Picón-Jaimes, Y. A. (2024). Eliminación de la transmisión vertical del VIH mediante terapia antirretroviral: ¿Es posible prevenir todos los casos? . Revista Hispanoamericana De Ciencias De La Salud, 10(1), 55–57. https://doi.org/10.56239/rhcs.2024.101.718
Sección
Cartas al Editor
Esta obra está bajo una licencia internacional Creative Commons Atribución-CompartirIgual 4.0.
La RHCS usa la licencia Creative Commons 4.0 Internacional (CC BY 4.0). Para obtener más información, visite https://creativecommons.org/licenses/by/4.0/